AzaSite® Inhibits Staphylococcus aureus and Coagulase-Negative Staphylococcus Biofilm Formation In Vitro

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Ocular Pharmacology and Therapeutics

• Publication date

  2010-11-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/jop.2010.0097PMID 21029017PMCID PMC2990284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii

  2009cited by this paper
• Staphylococcal biofilms.

  2008cited by this paper
• Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.

  2008cited by this paper
• Effect of antibacterials on biofilms.

  2008cited by this paper
• Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis

  2008cited by this paper
• The effects of antibiotics on in vitro biofilm model of periodontal disease.

  2008cited by this paper
• Subinhibitory concentrations of telithromycin, clarithromycin and azithromycin reduce methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo.

  2008cited by this paper
• Microbial biofilms in ophthalmology and infectious disease.

  2008cited by this paper
• Blepharitis: current strategies for diagnosis and management.

  2008cited by this paper
• Subinhibitory Concentrations of Azithromycin Decrease Nontypeable Haemophilus influenzae Biofilm Formation and Diminish Established Biofilms

  2007cited by this paper
• Clinical development of 1% azithromycin in DuraSite®, a topical azalide anti-infective for ocular surface therapy

  2007cited by this paper
• Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.

  2006cited by this paper
• Bacterial biofilms and ocular infections.

  2005cited by this paper
• Aminoglycoside antibiotics induce bacterial biofilm formation

  2005cited by this paper
• Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation

  2004cited by this paper
• Catheter-associated infections: pathogenesis affects prevention.

  2004cited by this paper
• Treatment of infections associated with surgical implants.

  2004cited by this paper
• The Role of Bacterial Biofilms in Ocular Infections

  2002cited by this paper
• The Detection of Bacteria and Bacterial Biofilms in Punctal Plug Holes

  2001cited by this paper
• Staphylococcus epidermidis biofilms: importance and implications.

  2001cited by this paper
• Biofilms and device-associated infections.

  2001cited by this paper
• Acute conjunctivitis associated with biofilm formation on a punctal plug.

  2000cited by this paper
• Eyelid disorders: diagnosis and management.

  1998cited by this paper
• The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro.

  1996cited by this paper
• Chronic blepharitis: a review.

  1995cited by this paper
• Biofilm-related infections in ophthalmology

  1995cited by this paper
• Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells.

  1993cited by this paper
• Macrolides induced suppression of virulence factors produced by Staphylococcus aureus.

  1993cited by this paper
• Staphylococcal blepharitis.

  1977cited by this paper

• Biofilm Production, Distribution of ica Genes, and Antibiotic Resistance in Clinical Coagulase-Negative Staphylococci Isolates

  2025cites this paper
• Antimicrobial effect of oral care gel containing hinokitiol and 4-isopropyl-3-methylphenol against intraoral pathogenic microorganisms

  2023cites this paper
• Anti-Infective Treatment and Resistance Is Rarely Problematic with Eye Infections

  2022cites this paper
• Speciation and Antibiotic Susceptibilities of Coagulase Negative Staphylococci Isolated from Ocular Infections

  2021cites this paper
• Sensitivity of Staphylococcal Biofilm to Selected Compounds of Plant Origin

  2021cites this paper
• The Role of Biofilms in Pathology of the Ocular Surface

  2021cites this paper
• Индивидуальный подход к лечению осложненных форм блефаритов: от теории к практике

  2020cites this paper
• Individual Approach to the Treatment of Complicated Forms of Blepharitis: from Theory to Practice

  2020cites this paper
• A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.

  2020cites this paper
• Topical semifluorinated alkane based azithromycin suspension for the management of ocular infections.

  2019cites this paper
• Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections

  2019cites this paper
• Update and critical appraisal of topical azithromycin ophthalmic 1% (Azasite) solution in the treatment of ocular infection

  2019cites this paper
• In Vitro Evaluation of a Hypochlorous Acid Hygiene Solution on Established Biofilms

  2018cites this paper
• Azithromycin‐loaded liposomes for enhanced topical treatment of methicillin‐resistant Staphyloccocus aureus (MRSA) infections

  2018cites this paper
• Modulation of Biofilm Growth by Sub‐Inhibitory Amounts of Antibacterial Substances

  2016cites this paper
• An Activity of Thioacyl Derivatives of 4-Aminoquinolinium Salts towards Biofilm Producing and Planktonic Forms of Coagulase-Negative Staphylococci

  2015cites this paper
• Comparison of scanning electron microscopy findings regarding biofilm colonization with microbiological results in nasolacrimal stents for external, endoscopic and transcanalicular dacryocystorhinostomy.

  2014cites this paper
• Clinical outcomes with besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis due to potentially consequential pathogens

  2014cites this paper
• Studies on ocular and parenteral application potentials of azithromycin- loaded anionic, cationic and neutral-charged emulsions.

  2013cites this paper
• Is antibiotic resistance a problem in the treatment of ophthalmic infections?

  2013cites this paper
• Review of Azithromycin Ophthalmic 1% Solution (AzaSite®) for the Treatment of Ocular Infections

  2012cites this paper
• Inhibition of Staphylococcus epidermidis Biofilm Formation by Traditional Thai Herbal Recipes Used for Wound Treatment

  2012cites this paper
• Clinical Ophthalmology Dovepress Update and Critical Appraisal of the Use of Topical Azithromycin Ophthalmic 1% (azasite ® ) Solution in the Treatment of Ocular Infections

  year unknowncites this paper